Dr. Kattesh V. Katti has Globally recognized as the ‘Father of Green Nanotechnology’, Professor Kattesh V. Katti, MSc Ed, PhD, DSc, FRSC, FNAI, FAIMB—is currently a Curators’ Professor of Radiology, Director, Institute of Green Nanotechnology, Medical School, University of Missouri, Columbia, USA. Dr. Katti is internationally renowned as a leader in the interconnecting fields of—chemistry, Materials Science, Radiopharmaceutical Sciences, Nanotechnology/Green Nanotechnology and Nanomedicine—for biomedical applications, specifically for Molecular Imaging and Therapy of living subjects. In 2026, Dr. Katti was selected as the ‘Top Innovator of the Year in Healthcare by the prestigious International Association of Top Professionals (IAOTP). Dr. Katti is a pioneer in the field of Nano-Ayurvedic Medicine—a new medical modality which he has discovered by the application of Nuclear Analytical, Radiochemical techniques and Green Nanotechnology to Ayurvedic-Holistic Medicine. In 2024, the US/European Union Patents and Trademarks office has granted the first ever US patent on Dr. Katti’s discovery of a new medical modality referred to as ‘Nano-Ayurvedic Medicine’ Several cancer therapy products, bionanomaterials and antibiotics, discovered by Dr. Katti, are approved by regulatory agencies for use in treating human patients. For his groundbreaking discoveries in SPECT/PET imaging and radiopharmaceuticals sciences, Dr. Katti has won the International Hevesy Medal Award—A Global award for excellence in Nuclear Medicine.

Jung Weon Lee (Ph.D) is a professor at Dept. of Pharmacy, College of Pharmacy, Seoul National University (SNU), Republic of Korea. He earned a Ph.D. degree in Pharmacology at University of North Carolina at Chapel Hill, NC, USA in 2000. He had a postdoc period at Memorial Sloan-Kettering Cancer Center, New York, NY, USA. In 2001, he came back to Korea, as an assistant professor at School of Medicine, SNU, Korea. In 2009, he moved to Dept. of Pharmacy, SNU and is now a full professor. His research has been mostly focused on how cellular functions, including morphological changes and diverse functions could occur at the molecular levels especially in contexts under controls or influence of a tetraspanin TM4SF5 protein using in vitro cell and in vivo animal models together with possible clinical samples. These days, his research team has a focus on exploring how TM4SF5 can function as an immune checkpoint and whether anti-TM4SF5 reagents can be new modalities for the purposes of immune therapy against chronic liver diseases

Will be updated soon...

As an accomplished Senior Lecturer in Pharmacology at Perdana University, Graduate School of Medicine, and recently promoted to Deputy Dean, I am deeply committed to advancing medical education and research. With 13 years of experience in drug discovery, natural product research, and both animal and clinical research, my career has been dedicated to pushing the boundaries of medical science. I am passionate about creating and nurturing a vibrant academic environment that encourages innovation and critical thinking. My work is centered on translating complex research into practical healthcare solutions, enhancing both understanding and outcomes in the medical field. As a leader, I am focused on guiding the Graduate School of Medicine to new achievements, fostering excellence in research and education. I believe in the power of interdisciplinary collaboration to solve intricate medical challenges and am eager to connect with like-minded academics, researchers, and industry professionals. Together, we can shape the future of pharmacology and medical education, driving forward meaningful advancements in healthcare.